These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32256201)
1. Biomarkers and brains: situating dementia in the laboratory and in the memory clinic. Latimer J; Hillman A New Genet Soc; 2020; 39(1):80-100. PubMed ID: 32256201 [TBL] [Abstract][Full Text] [Related]
2. [Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia]. Bürge M; Bieri G; Brühlmeier M; Colombo F; Demonet JF; Felbecker A; Georgescu D; Gietl A; Brioschi Guevara A; Jüngling F; Kirsch E; Kressig RW; Kulic L; Monsch AU; Ott M; Pihan H; Popp J; Rampa L; Rüegger-Frey B; Schneitter M; Unschuld PG; von Gunten A; Weinheimer B; Wiest R; Savaskan E Praxis (Bern 1994); 2018 Apr; 107(8):1-17. PubMed ID: 31589108 [TBL] [Abstract][Full Text] [Related]
3. A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia. van der Ende EL; Bron EE; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; Dopper EGP; Wilke C; Synofzik M; Heller C; Swift IJ; Sogorb-Esteve A; Bouzigues A; Borroni B; Sanchez-Valle R; Moreno F; Graff C; Laforce R; Galimberti D; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; Rowe JB; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Pijnenburg YAL; Sorbi S; Zetterberg H; Niessen WJ; Rohrer JD; Klein S; van Swieten JC; Venkatraghavan V; Seelaar H; Brain; 2022 Jun; 145(5):1805-1817. PubMed ID: 34633446 [TBL] [Abstract][Full Text] [Related]
5. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study. Perna L; Stocker H; Burow L; Beyer L; Trares K; Kurz C; Gürsel S; Holleczek B; Tatò M; Beyreuther K; Mons U; Gerwert K; Perneczky R; Schöttker B; Brenner H Alzheimers Res Ther; 2023 Nov; 15(1):198. PubMed ID: 37951931 [TBL] [Abstract][Full Text] [Related]
6. β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population. Rosenberg A; Öhlund-Wistbacka U; Hall A; Bonnard A; Hagman G; Rydén M; Thunborg C; Wiggenraad F; Sandebring-Matton A; Solomon A; Kivipelto M Neurology; 2022 Nov; 99(19):e2102-e2113. PubMed ID: 36130840 [TBL] [Abstract][Full Text] [Related]
7. [Biomarkers for the diagnosis of cognitive impairment - Recommendations from the Swiss Memory Clinics]. Popp J; Georgescu D; Bürge M; Mundwiler-Pachlatko E; Bernasconi L; Felbecker A Praxis (Bern 1994); 2022; 111(13):738-744. PubMed ID: 36221969 [TBL] [Abstract][Full Text] [Related]
8. [Recommendations of Swiss Memory Clinics for the Diagnosis of Dementia]. Bürge M; Bieri G; Brühlmeier M; Colombo F; Demonet JF; Felbecker A; Georgescu D; Gietl A; Brioschi Guevara A; Jüngling F; Kirsch E; Kressig RW; Kulic L; Monsch AU; Ott M; Pihan H; Popp J; Rampa L; Rüegger-Frey B; Schneitter M; Unschuld PG; von Gunten A; Weinheimer B; Wiest R; Savaskan E Praxis (Bern 1994); 2018 Apr; 107(8):435-451. PubMed ID: 29642795 [TBL] [Abstract][Full Text] [Related]
9. Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients. Knapskog AB; Eldholm RS; Braekhus A; Engedal K; Saltvedt I BMC Geriatr; 2017 Sep; 17(1):210. PubMed ID: 28893185 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. Lewczuk P; Riederer P; O'Bryant SE; Verbeek MM; Dubois B; Visser PJ; Jellinger KA; Engelborghs S; Ramirez A; Parnetti L; Jack CR; Teunissen CE; Hampel H; Lleó A; Jessen F; Glodzik L; de Leon MJ; Fagan AM; Molinuevo JL; Jansen WJ; Winblad B; Shaw LM; Andreasson U; Otto M; Mollenhauer B; Wiltfang J; Turner MR; Zerr I; Handels R; Thompson AG; Johansson G; Ermann N; Trojanowski JQ; Karaca I; Wagner H; Oeckl P; van Waalwijk van Doorn L; Bjerke M; Kapogiannis D; Kuiperij HB; Farotti L; Li Y; Gordon BA; Epelbaum S; Vos SJB; Klijn CJM; Van Nostrand WE; Minguillon C; Schmitz M; Gallo C; Lopez Mato A; Thibaut F; Lista S; Alcolea D; Zetterberg H; Blennow K; Kornhuber J; World J Biol Psychiatry; 2018 Jun; 19(4):244-328. PubMed ID: 29076399 [TBL] [Abstract][Full Text] [Related]
11. How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting? Meijs AP; Claassen JA; Rikkert MG; Schalk BW; Meulenbroek O; Kessels RP; Melis RJ Age Ageing; 2015 Jan; 44(1):72-7. PubMed ID: 24847028 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer and vascular dementias and driving. A prospective road and laboratory study. Fitten LJ; Perryman KM; Wilkinson CJ; Little RJ; Burns MM; Pachana N; Mervis JR; Malmgren R; Siembieda DW; Ganzell S JAMA; 1995 May; 273(17):1360-5. PubMed ID: 7715061 [TBL] [Abstract][Full Text] [Related]
13. The current status of blood epigenetic biomarkers for dementia. Fransquet PD; Ryan J Crit Rev Clin Lab Sci; 2019 Nov; 56(7):435-457. PubMed ID: 31328605 [TBL] [Abstract][Full Text] [Related]
14. Towards diagnostic conversational profiles of patients presenting with dementia or functional memory disorders to memory clinics. Elsey C; Drew P; Jones D; Blackburn D; Wakefield S; Harkness K; Venneri A; Reuber M Patient Educ Couns; 2015 Sep; 98(9):1071-7. PubMed ID: 26116418 [TBL] [Abstract][Full Text] [Related]
15. Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia. Shepherd A; Tyebji S; Hannan AJ; Burrows EL J Mol Neurosci; 2016 Nov; 60(3):371-382. PubMed ID: 27637601 [TBL] [Abstract][Full Text] [Related]
16. Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the "Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment" (TRACE-VCI) Study. Boomsma JMF; Exalto LG; Barkhof F; van den Berg E; de Bresser J; Heinen R; Koek HL; Prins ND; Scheltens P; Weinstein HC; van der Flier WM; Biessels GJ JMIR Res Protoc; 2017 Apr; 6(4):e60. PubMed ID: 28428166 [TBL] [Abstract][Full Text] [Related]
17. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Henneman WJ; Sluimer JD; Cordonnier C; Baak MM; Scheltens P; Barkhof F; van der Flier WM Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551 [TBL] [Abstract][Full Text] [Related]
18. Montreal Cognitive Assessment for the detection of dementia. Davis DH; Creavin ST; Yip JL; Noel-Storr AH; Brayne C; Cullum S Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010775. PubMed ID: 34255351 [TBL] [Abstract][Full Text] [Related]
19. A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study. Axelsen TM; Bager C; Bihlet A; Karsdal MA; Henriksen K; Tang MHE J Prev Alzheimers Dis; 2023; 10(3):536-542. PubMed ID: 37357295 [TBL] [Abstract][Full Text] [Related]